secwatch.observer — SEC 8-K summary
======================================

Issuer:     VYNE Therapeutics Inc. (VYNE)
CIK:        0001566044
Form:       8-K
Filed at:   2026-07-14T12:12:23+00:00
Accession:  0001104659-26-083356
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Yarrow Bioscience publishes investor presentation; VYNE makes available on website
--------------------------------------------------------------------------------

- Yarrow Bioscience published an investor presentation dated July 14, 2026, which VYNE made available on its website.
- The presentation is related to the proposed transaction between VYNE and Yarrow, as referenced in the S-4 registration statement.
- No specific financial or operational details from the presentation are included in the filing text provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1566044/000110465926083356/0001104659-26-083356-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1566044/000110465926083356/tm2620382d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-083356

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer